Enyo

ENYO Pharma is a clinical stage biotech company based in Lyon. The company has developed an innovative and disruptive drug discovery engine allowing to develop patentable molecules directed against new therapeutic intracellular targets. ENYO Pharma’s founders have deciphered virus-host interactions and built a unique concept based on virus bio-mimetism. ENYO Pharma got a convertible loan from BPI (Banque Publique d’Investissement) to develop a small molecule for severe influenza with a new mode of action. ENYO Pharma masters drug development and also started several early stage business development with Big pharma.